Suppr超能文献

[子宫颈和子宫体恶性肿瘤患者可溶性分子CD38的总分数及寡聚体分数的血清水平]

[THE SERUM LEVEL OF TOTAL AND OLIGOMERIC FRACTIONS OF SOLUBLE MOLECULES CD38 UNDER MALIGNANT TUMORS OF CERVIX AND UTERINE BODY].

作者信息

Novikov V V, Mamaeva M E, Aliasova A V, Hazov M V, Kasatova E S, Shumilova S V, Karaulov A V

出版信息

Klin Lab Diagn. 2015 May;60(5):32-6.

Abstract

The immune-enzyme analysis was applied using anti-CD38 monoclonal antibodies to detect serum content of total (sCD38) and oligomeric fractions of soluble molecules CD38 (ol.sCD38) in patients with cervix cancer and malignant neoplasms of uterine body. The three- and four-fold increasing of serum level of sCD38 is demonstrated both under cervix cancer and malignant neoplasms of uterine body. The level of ol.sCD38 decreased in patients with cervix cancer and increased in case of patients with malignant neoplasms of uterine body. The serum content of ol.sCD38 was increased under adenocarcinoma of uterus and glandular epidermoid cancer. The content of sCD38 increased under adenocarcinoma of uterus but decreased under sarcoma of uterus. The highest level of soluble molecules of CD38 was established in patients with highly differentiated tumors and under invasion into endometrium but not into miometrium. On the whole, alterations in content of soluble molecules CD38 are associated with characteristics of tumor process that indicates at their monitoring significance under malignant neoplasms of uterus.

摘要

采用抗CD38单克隆抗体进行免疫酶分析,以检测宫颈癌和子宫体恶性肿瘤患者血清中可溶性分子CD38的总量(sCD38)和寡聚体部分(ol.sCD38)的含量。宫颈癌和子宫体恶性肿瘤患者的血清sCD38水平均显示出3倍和4倍的升高。宫颈癌患者的ol.sCD38水平降低,而子宫体恶性肿瘤患者的ol.sCD38水平升高。子宫腺癌和腺鳞癌患者的血清ol.sCD38含量增加。子宫腺癌患者的sCD38含量增加,但子宫肉瘤患者的sCD38含量降低。CD38可溶性分子水平在高分化肿瘤患者以及肿瘤侵犯子宫内膜而非肌层时最高。总体而言,可溶性分子CD38含量的改变与肿瘤进程的特征相关,这表明它们在子宫恶性肿瘤监测中具有重要意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验